在中国3至8岁儿童中四价流感病毒裂解疫苗2针次免疫程序的探索研究
[Translation] An exploratory study on the two-dose immunization schedule of quadrivalent influenza virus split vaccine in children aged 3 to 8 years in China
在中国3-8岁儿童中进行四价流感病毒裂解疫苗2针次免疫程序免疫原性和安全性探索研究。
[Translation] An exploratory study on the immunogenicity and safety of a two-dose immunization schedule of quadrivalent influenza virus split vaccine in children aged 3-8 years in China.
健康人群单中心、随机、盲态、同类制品平行对照、非劣效设计的冻干人用狂犬病疫苗(Vero 细胞)III期临床试验
[Translation] A Phase III clinical trial of freeze-dried human rabies vaccine (Vero cells) in healthy population with a single center, randomized, blinded, parallel control of similar products and non-inferiority design
评价江苏金迪克生物技术有限公司研制的冻干人用狂犬病疫苗(Vero 细胞)在健康人群中接种的免疫原性和安全性
[Translation] To evaluate the immunogenicity and safety of freeze-dried human rabies vaccine (Vero cells) developed by Jiangsu Jindik Biotechnology Co., Ltd. in healthy people
在满3周岁以上健康人群中开展的流感病毒裂解疫苗(四价)随机、双盲、阳性对照、非劣效设计的Ⅲ期临床试验
[Translation] A randomized, double-blind, positive-controlled, non-inferiority designed Phase III clinical trial of influenza virus split vaccine (quadrivalent) in healthy people aged 3 years and above
评价江苏金迪克生物技术有限公司研制的流感病毒裂解疫苗(四价)在满3周岁以上健康人群中接种的免疫原性和安全性。
[Translation] To evaluate the immunogenicity and safety of the influenza virus split vaccine (quadrivalent) developed by Jiangsu Jindik Biotechnology Co., Ltd. in healthy people aged 3 years and above.
100 Clinical Results associated with Beijing Jindike Biotech Institute Ltd.
0 Patents (Medical) associated with Beijing Jindike Biotech Institute Ltd.
100 Deals associated with Beijing Jindike Biotech Institute Ltd.
100 Translational Medicine associated with Beijing Jindike Biotech Institute Ltd.